2 Patents
- US121730632024Targeting Modules for Universal Chimeric Antigen Receptor Expressing Immune Cells and Use in the Treatment of Cancer, Infections and Autoimmune Disorders
Avencell Europe GmbH
0 cites - US115604262023Targeting Modules for Universal Chimeric Antigen Receptor Expressing Immune Cells and Use in the Treatment of Cancer Infections and Autoimmune Disorders
Avencell Europe GmbH
0 cites